CX 04328

CAS No. 957890-42-5

CX 04328 ( LEDGIN-6 )

Catalog No. M16841 CAS No. 957890-42-5

CX 04328 (LEDGIN-6) is an allosteric HIV-1 integrase inhibitor that inhibits the LEDGF/p75-integrase interaction with IC50 of 1.37 uM.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 262 Get Quote
50MG 1188 Get Quote
100MG 1791 Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    CX 04328
  • Note
    Research use only, not for human use.
  • Brief Description
    CX 04328 (LEDGIN-6) is an allosteric HIV-1 integrase inhibitor that inhibits the LEDGF/p75-integrase interaction with IC50 of 1.37 uM.
  • Description
    CX 04328 (LEDGIN-6) is an allosteric HIV-1 integrase inhibitor that inhibits the LEDGF/p75-integrase interaction with IC50 of 1.37 uM, antiviral activity EC50 of 2.35 uM.
  • Synonyms
    LEDGIN-6
  • Pathway
    Microbiology/Virology
  • Target
    HIV
  • Recptor
    HIV
  • Research Area
    Infection
  • Indication
    ——

Chemical Information

  • CAS Number
    957890-42-5
  • Formula Weight
    353.85
  • Molecular Formula
    C21H20ClNO2
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO : ≥ 100 mg/mL 282.61 mM; H2O : < 0.1 mg/mL
  • SMILES
    CCCC(C1=C(C2=CC=CC=C2)C3=CC(Cl)=CC=C3N=C1C)C(O)=O
  • Chemical Name
    2-(6-chloro-2-methyl-4-phenylquinolin-3-yl)pentanoic acid

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Christ F, et al. Nat Chem Biol. 2010 Jun;6(6):442-8.
molnova catalog
related products
  • MUT-A

    MUT-A is a novel potent, HIV-1 Integrase IN-LEDGF allosteric inhibitor, shows potent anti-HIV activity with EC50 of 32 nM and 12 nM for NL4-3 or HxB2 HIV-1 strains, respectively.

  • Escin IA;Aescin IA

    Escin IA is a triterpene saponin isolated from horse chestnut which inhibits HIV-1 protease with IC50 values of 35 μM. Escin IA has anti-TNBC metastasis activity and its action mechanisms involved inhibition of epithelial-mesenchymal transition process by down-regulating LOXL2 expression.

  • Saquinavir

    Apotent and selective inhibitor of HIV-1 protease with IC50 of 0.5-6 nM in cell assays.